Systemic T Cell–independent Tumor Immunity after Transplantation of Universal Receptor–modified Bone Marrow into SCID Mice

por Hege, Kristen M., Cooke, Keegan S., Finer, Mitchell H., Zsebo, Krisztina M., Roberts, Margo R.
Publicado 1996

Innate and adaptive immunity contribute to the anti-tumor mechanisms of action of OncoVEX(mGM-CSF)

por Cooke, Keegan, Fitzgerald, Karen, Yang, Becky, Mitchell, Petia, Estrada, Juan, Pedro, Beltran, Moesta, Achim K
Publicado 2015

OncoVEX(mGM-CSF)expands tumor antigen-specific CD8+ T-cell response in preclinical models

por Estrada, Juan, Zhan, Jinghui, Mitchell, Petia, Werner, Jonathan, Beltran, Pedro J, DeVoss, Jason, Qing, Jing, Cooke, Keegan S
Publicado 2023

Oncovex MGM-CSF –mediated regression of contralateral (non-injected) tumors in the A20 murine lymphoma model does not involve direct viral oncolysis

por Cooke, Keegan, Rottman, James, Zhan, Jinghui, Mitchell, Petia, Ikotun, Oluwatayo, Yerby, Brittany, Chong, Angela, Glaus, Charles, Moesta, Achim K, Pedro, Beltran
Publicado 2015

MAPK pathway inhibition induces MET and GAB1 levels, priming BRAF mutant melanoma for rescue by hepatocyte growth factor

por Caenepeel, Sean, Cooke, Keegan, Wadsworth, Sarah, Huang, Guo, Robert, Lidia, Moreno, Blanca Homet, Parisi, Giulia, Cajulis, Elaina, Kendall, Richard, Beltran, Pedro, Ribas, Antoni, Coxon, Angela, Hughes, Paul E.
Publicado 2017